CClinicalTrials.gg
Not yet recruitingNCT07525492Updated Apr 13, 2026

Die-logue Program for Community Dwelling Adults: A Randomized Controlled Trial

An interventional study of Death Conversation and Online ACP Education in Death Attitude (Implicit/Explicit), Death Anxiety and End of Life Care, sponsored by National University of Singapore. Not yet recruiting at 1 site in Singapore. Open to participants aged 40 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-13.

Sponsored by National University of Singapore · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
148
Allocation
Randomized
Ages
40 Years to 60 Years
Sex
All
01

Study summary

The goal of this clinical trial is to evaluate whether the Die-logue program can improve attitudes toward death, coping with death, and readiness for advance care planning (ACP) among community-dwelling middle-aged adults aged 40-60 years who have not completed any advance directives and not diagnosed with any life limiting diseases.

This study aims to address the following research questions:

  • Does the Die-logue program improve community-dwelling middle-aged adults' attitudes towards death, ability to cope with death, readiness and uptake for Advanced Care Planning (ACP).
  • What are community-dwelling middle-aged adults' perceptions of advance care planning, death and dying, and their experiences of participation in the Die-logue program.

Researchers will compare participants who receive the Die-logue program (death conversation and online ACP education) with participants who receive only the online ACP education to see if informal death conversations improve attitudes toward death, coping with death, and readiness for ACP.

Participants will:

  • Complete online questionnaires measuring attitudes toward death, coping with death, and readiness for advance care planning.
  • Participate in a facilitator-led group discussion session about perceptions of death, coping with death, and readiness for ACP (intervention group only).
  • Complete an asynchronous online ACP education session consisting of short recorded videos and an online discussion forum (both intervention and control group).
  • Complete follow-up surveys, including a 6-month follow-up assessing whether they have undertaken advance care planning.
02

Conditions studied

  • Death Attitude (Implicit/Explicit)
  • Death Anxiety
  • End of Life Care
  • Advanced Care Planning (ACP)

Keywords

  • Death Conversation
  • Death Anxiety
  • Advance Care Planning
  • Death Attitude
03

Who can participate

Ages eligible
40 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Between the ages of 40 to 60 years
  • Able to comprehend the English language
  • Have not completed any form of advance directives
  • Able and willing to participate in the Die-logue programme and surveys

Exclusion criteria

Exclusion Criteria:

  • Individuals diagnosed with any life limiting diseases
  • Individuals with self-reported history of mental health disorders or neurological disorders
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
148 participants (estimated)

Study arms

  • Experimental
    Intervention Group

    Participants in this arm will receive the two-session Die-logue Program. Session 1 is an on site, facilitator-led group discussion lasting 2 hours, covering: 1. Perceptions of death and dying. 2. Coping with death. 3. Readiness for Advance Care Planning (ACP). Session 2 is an online asynchronous learning session with short videos on ACP with discussion forums.

    Behavioral: Death Conversation · Behavioral: Online ACP Education

  • Active comparator
    Control Group

    Participants in this arm will only receive the online ACP education component, identical to Session 2 of the Die-logue programme. No facilitator-led group discussions are provided.

    Behavioral: Online ACP Education

Interventions

  • BehavioralDeath Conversation

    On site, facilitator-led group discussion lasting 2 hours, covering: 1) Perceptions of death and dying. 2) Coping with death. 3) Readiness for Advance Care Planning (ACP)

  • BehavioralOnline ACP Education

    An online asynchronous learning session with short videos on ACP with discussion forums.

05

What researchers measure

Primary outcomes

  1. Death Attitudes

    Death Attitude Profile Revised Scale (DAP-R)

    Time frame: Before intervention

  2. Death Attitudes

    Death Attitude Profile Revised Scale (DAP-R)

    Time frame: Immediately after intervention

Secondary outcomes

  1. Coping with Death

    Coping with Death Scale - Short Form (CDS-SF)

    Time frame: Before intervention

  2. Coping with Death

    Coping with Death Scale - Short Form (CDS-SF)

    Time frame: Immediately after intervention

  3. Coping with Death

    Coping with Death Scale - Short Form (CDS-SF)

    Time frame: 6 months after intervention

  4. Death Attitudes

    Death Attitude Profile Revised Scale (DAP-R)

    Time frame: 6 months after intervention

  5. Readiness for Advance Care Planning

    Readiness for Advance Care Planning (RACP) Scale

    Time frame: Before intervention

  6. Readiness for Advance Care Planning

    Readiness for Advance Care Planning (RACP) Scale

    Time frame: Immediately after intervention

  7. Readiness for Advance Care Planning

    Readiness for Advance Care Planning (RACP) Scale

    Time frame: 6 months after intervention

  8. Uptake of Advance Care Planning

    Self-reported completion of Advance Care Planning Activities

    Time frame: 6 months after intervention

06

Study locations

1 site
  • National University of Singapore
    Singapore, Singapore
07

Registry details

Key details

Study ID
NCT07525492
Lead sponsor
National University of Singapore
Responsible party
Ang Wei How Darryl (Research Assistant Professor, National University of Singapore) — Principal investigator
First posted
Apr 13, 2026
Start date
Apr 1, 2026 (estimated)
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Apr 13, 2026

Study contacts

Darryl Ang, PhD
Contact
darrylang@nus.edu.sg
+65 65167792

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion